Back

Ferric derisomaltose in heart failure with iron deficiency - an update from the IRONMAN trial

11 May 2024 (08:00 - 20:00)
Organised by: Logo
Congress Presentation Part of: Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice? Anaemia/Iron Deficiency Open Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Professor Paul Kalra

Portsmouth Hospitals NHS Trust, Portsmouth (United Kingdom of Great Britain & Northern Ireland)

5 More presentations in this session

Presentation thumbnail
Welcome and introduction
Professor T. McDonagh (London, GB) Professor J. Cleland (Glasgow, GB)
Slides
Presentation thumbnail
Ferric carboxymaltose in heart failure with iron deficiency - the HEART-FID and AFFIRM-AHF trials
Doctor R. Mentz (Durham, US)
Slides
Presentation thumbnail
What do the new ESC guidelines recommend
Professor T. McDonagh (London, GB)
Slides
Presentation thumbnail
What's still to come
Professor J. Cleland (Glasgow, GB)
Slides
Presentation thumbnail
Q&A

Access the full session

Session thumbnail
Trials of IV iron: what we got right and what we didn’t. How can the new ESC guidelines help improving clinical practice?
Video

The Event

Event poster

Heart Failure 2024

11 May - 14 May 2024
You may be interested in
thumbnail
Congress Session
Moving targets of treatment in heart failure
thumbnail
Congress Session
IV iron – What is the current status and what are the future perspectives
thumbnail
Congress Presentation
Investigation and management of iron deficiency in acute decompensated heart failure admissions in an Irish tertiary referral hospital

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources